InvestorsHub Logo
Followers 80
Posts 1038
Boards Moderated 0
Alias Born 06/26/2014

Re: None

Tuesday, 10/13/2015 7:02:08 AM

Tuesday, October 13, 2015 7:02:08 AM

Post# of 425800
JEFFERIES FLASH NOTE (13-OCT-15):

* First Amendment Win Could Expand Vascepa Market Opp 10x
* ANCHOR Impact Could Be Seen In The Next Quarters
* AMRN has decided to rollout their new ANCHOR marketing material in a sequence of modules to avoid inundating physicians
* Future modules are planned to detail inflammation benefits of Vascepa and the Japanese JELIS study that showed a CV outcomes benefit for E-EPA
* Interim REDUCE-IT Analysis On Track For 2016
* we believe that a favorable outcome in the interim analysis would lead to major upside beyond current levels
* International Partnerships May Continue As Non-Dilutive Sources Of Cash
(THAT IS WRITTEN SPECIFICALLY FOR MOGWAI)
* we believe that partnerships for Vascepa in a contingent of international countries could be non-dilutive sources of cash

I will attach the pdf file in due time

LONG & STRONG !!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News